Speaker illustration

Professor Alex Spyropoulos

Northwell Health, New York (United States of America)

The HEP-COVID Trial

Event: ESC Congress 2021 - The Digital Experience

Topic: Venous Thromboembolism

Session: Latest Science in COVID-19

Thumbnail

State of the Art - Optimizing the prevention of venous thromboembolism

Event: ESC Congress 2018

Topic: Treatment

Session: Progress in anticoagulation for venous thromboembolism

Thumbnail

MARINER.

Event: ESC Congress 2018

Topic: Prevention

Session: Meet the trialist - MARINER - Medically Ill Patient Assessment of Rivaroxaban Versus Placebo IN Reducing Post-Discharge Venous Thrombo-Embolism Risk

Thumbnail

MARINER - Medically Ill Patient Assessment of Rivaroxaban Versus Placebo IN Reducing Post-Discharge Venous Thrombo-Embolism Risk

Event: ESC Congress 2018

Topic: Prevention

Session: Hot Line Session 1

Thumbnail

The journey continues: looking ahead with dabigatran.

Event: ESC CONGRESS 2014

Topic: Thrombosis and coagulation

Session: Changing the face of anticoagulation: 5 years since RE-LY®

Thumbnail

This platform is supported by

logo Novo Nordisk